AndresMatosoMD

Pathology • Baltimore, MD

Gastrointestinal & Hepatobiliary Pathology, Genitourinary Pathology, Anatomic Pathology, Clinical Pathology

GU Pathology Fellow

Join to view full profile

Dr. Matoso is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Matoso's full profile

Already have an account?

Office
401 N Broadway St
Baltimore, MD 21287
Phone+1 410-955-4053

Fax+1 410-614-1287

Summary

I am an AP/CP board certified pathologist with sub specialty expertise in GI and GU pathology.

Education & Training

Department of Pathology and Laboratory Medicine Johns Hopkins HospitalFellowship, Urologic Pathology, 2013
Rhode Island Medical CenterFellowship, Gastrointestinal Pathology, 2012 - 2013
Rhode Island Hospital/Brown University2008 - 2012
Weill Cornell MedicinePost-Doctoral Fellowship, 2006 - 2008
University of Buenos Aires2002 - 2005
University of Buenos AiresClass of 2001

Certifications & Licensure

FL State Medical License 2024 - 2026
MD State Medical License 2012 - 2025
DC State Medical License 2016 - 2024
RI State Medical License 2007 - 2018
American Board of Pathology Pathology - Anatomic/Pathology - Clinical
American Board of PathologyAP/CP

Awards, Honors, & Recognition

Stowell-Orbison Award United States & Canadian Academy of Pathology, 2013
New Investigator Award Winner Rhode Island Hospital/Brown University, 2012
New Investigator Award Finalist Rhode Island Hospital/Brown University, 2010
Diploma of Honor University of Buenos Aires, 2003
Join now to see all

Publications & Presentations

PubMed

43 citations
Clinical Restaging and Tumor Sequencing are Inaccurate Indicators of Response to Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer
Russell E.N. Becker, Alexa R. Meyer, Aaron Brant, Adam C. Reese, Michael J. Biles
European Urology. 2021-03-01
17 citations
GLI1 Gene Alterations in Neoplasms of the Genitourinary and Gynecologic Tract.
Pedram Argani, Baris Boyraz, Esther Oliva, Andres Matoso, John Gross
The American Journal of Surgical Pathology. 2022-05-01
109 citations
Defining clinically significant prostate cancer on the basis of pathological findings.
Andres Matoso, Jonathan I. Epstein
Histopathology. 2019-01-01

Journal Articles

Association of Impaired Spermatogenesis with the Use of Immune Checkpoint Inhibitors in Patients with Metastatic Melanoma
Jody E Hooper, Andres Matoso, JAMA Oncology
Expression Microarray Analysis Identifies of Novel Protein Markers in Eosinophilic Esophagitis.
Matoso A, Mukkada VA, Lu S, Monahan R, Cleveland K, Noble L, Mangray S, Resnick MB, Mod Pathol
Sympathetic ophtalmia following enucleation.
Tseng VL, Matoso A, Hofmann RJ, Graefes Arch Clin Exp Ophthalmol

Books/Book Chapters

Emerging Research and Treatments in Renal Cell Carcinoma.
Chapter: Steroid Receptors in Renal Cell Carcinoma
Yakirevich E, Matoso A, MorrisDJ and ResnickMBEditors: Robert J. Amato.
Cancer and Stem Cells.
Chapter: Cancer Stem Cellsin Solid Tumors
Page 87 - 110Matoso Aand Nikitin A YuEditors: Dittmar, T. and Zänker, K. S.Nova Science

Abstracts/Posters

Molecular Mechanismsof Met Regulation by p53 in Ovarian Cancer.
Matoso A, Hwang C-I, Flesken-Nikitin A, Ellenson LH, Nikitin AY, Center for Vertebrate Genomics, Annual Symposium
Mutually Exclusive Mutations between Men1 and Rb in Neuroendocrine Neoplasia.
Matoso A, Zhou Z, Hayama R, Flesken-Nikitin A, Nikitin AY, Cornell University
ALDH1 Expression in Bladder Cancer Correlates with Histopathologic Indicators of Poor Prognosis.
Elsamra SE, Matoso A, Singh K, Tavares R, Noble L, Renzulli J, Haleblian G, Resnick MB, Wang LJ, Pareek G, New England Section of the American Urological Association
Differentiation Syndrome in a Patient with Acute Promyelocytic Leukemia.
Fabre MV, Matoso A, Khurshid H, Society of General Internal Medicine
66 Year Old Male with Unilateral Proptosis.
Fabre MV, Matoso A, Diaz JA, Memorial Hospital of Rhode Island
Stem Cell Marker ALDH1 Expression Correlates with Unfavorable Prognosis in Prostate Cancer.
Matoso A, Tavares R, Zhang Y, Noble L, Jacob R, Renzulli J, Resnick MB, Pareek G, Haleblian G, Wang LJ, United States and Canadian Academy of PathologyAnnual Meeting
Morphologic and Immunohistochemical Characterization of 5 Cases of Spindle Cell Metaplasia of the Thyroid.
Matoso A, Easley SE, Mangray S, Jacob R, Noble LC, Tavares R, DeLellis RA, Lifespan Research Celebration Day
Expression of Putative Stem Cell Markers ALDH1 and CD133 in Urothelial Carcinoma of the Bladder.
Matoso A, Sciandra KT, Elsamra S, Singh K, Renzulli J, Jacob R, Tavares R, Haleblian G, Noble L, Pareek G, Resnick MB, Wang LJ, United States and Canadian Academy of Pathology Annual Meeting
Join now to see all

Lectures

Differentially expressed proteins in eosinophilic esophagitis: identification of easily detectable markers with potential diagnostic utility.
20th Annual Hospital Research Celebration
Expression of stem cell marker ALDH1 correlates with muscle invasion in transitional cell carcinoma of the bladder.
18th Annual Hospital Research Celebration
Prostatic Lesions of Ductal Morphology.
Pathology Grand Rounds, Rhode Island Hospital
Diagnostic and Prognostic Implications of Histologic Variants of Urothelial Carcinoma.
Pathology Grand Rounds, Rhode Island Hospital
Germ Cell Tumors of the Testis.
Pathology Grand Rounds, Rhode Island Hospital
Comparison of Thyroid Transcription Factor-1 (TTF-1) Expression by Two Monoclonal Antibodies in Lung and Non-Lung Primary Tumors.
United States and Canadian Academy of Pathologists Annual Meeting
Spindle Cell Metaplasia of the Thyroid.
The New England Society of Pathologists
Prostate cancer histopathologic pitfalls: a review of benign mimickers.
Pathology Grand Rounds, Rhode Island Hospital
Invasion and metastasis in ovarian cancer.
Pathology Grand Rounds, Rhode Island Hospital
Join now to see all